Aberrant methylation is one of the driving forces of cancer genome development. Although the rate of methylation appears massively variable across the genome, it is mainly observed in histone modifica
The activities of the promoters were determined as described in “Materials and Methods” and are presented in percentage relative to their controls. Data are mean ± SE of at least three independent exp